PPD offers a broad range of early development services, Phase I clinical trial services and nonclinical consulting.
Expertise in nearly 40 psychiatric and neurological disorders, and clinically trained neuroscience teams led by scientists and clinicians with extensive neuroscience experience.
As clinical trial investigators, physicians play an integral role in the development of life-changing medicines.
View all of PPD's news releases.
Jie Ding, associate director of development and validation at the PPD® Laboratories’ GMP lab, discusses liquid chromatography-mass spectrometry in drug discovery and development.
Kirsten Messmer, Ph.D., R.A.C., principal regulatory affairs specialist, details changes in regulatory guidelines for first-in-human trials.
Stephen Peroutka, vice president and therapeutic area head in neuroscience, shares his thoughts on the importance and outlook of conducting clinical trials for Alzheimer’s disease.
Regulatory affairs experts at PPD, Alistair Davidson and Vincenzo Cannizzaro, reflect on how the United Kingdom's departure from the European Union might impact the pharmaceutical industry.
Bill Wang, director of regulatory affairs, discusses China's regulatory environment in the second-largest pharmaceutical market in the world.
We want to hear from you
Register in PPD's Database
© 2017 Pharmaceutical Product Development, LLC. All rights reserved.